Search clinical trials for: Sunitinib (SU011248)

Total 494 results

European Organisation for Research and Treatment...

Terminated

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

Lung Cancer

Netherlands
California Pacific Medical Center Research Institute
Pfizer

Withdrawn

A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma

Melanoma

United States
Baylor Breast Care Center

Terminated

Brain Mets - Capecitabine Plus Sunitinib and WBRT

Breast Cancer

United States
Hoosier Cancer Research Network
Pfizer

Completed

Sutent + Taxol for Advanced Esophageal Cancer

Esophageal Cancer

United States
Hospital del Mar

Unknown

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer

Spain
Samsung Medical Center

Completed

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

Advanced Gastric Cancer

Korea, Republic of
Medical University of Vienna

Unknown

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Hormone Refractory Prostate Cancer

Austria
Taipei Medical University Hospital
Pfizer; TTY Biopharm

Unknown

Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Taiwan
NCIC Clinical Trials Group

Completed

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Canada
Pfizer
Novartis; Keyrus Biopharma

Completed

OPALINE : A Study Of Morbidity And Mortality At 2 Years (OPALINE)

Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive

France
University Health Network, Toronto
Pfizer

Completed

Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer

Esophageal Cancer

Canada
Pfizer

Completed

Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer

Stomach Neoplasms

Korea, Republic of
Pfizer

Completed

Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer

Stomach Neoplasms

Spain
Andrea Harzstark
Novartis

Withdrawn

Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)

Locally Metastatic Malignant Neoplasm
Ludwig Institute for Cancer Research
Pfizer; Heidelberg Pharma AG

Terminated

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma (RCC)

Australia
SCRI Development Innovations, LLC
Pfizer

Completed

Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer

Small Cell Lung Cancer

United States
Central European Society for Anticancer Drug Research

Completed

First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer

Germany, Switzerland
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumor

United States
Exelixis

Recruiting

Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma (STELLAR-304)

Non-Clear Cell Renal Cell Carcinoma

United States, Spain, Korea, Republic of, Italy, Australia, France, Argentina, Brazil, Chile, Czechia, Finland, Germany, Malaysia, Netherlands, Poland, Thailand
GlaxoSmithKline

Completed

Hepatic Monitoring for Pazopanib

Carcinoma, Renal Cell
RenJi Hospital
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Recruiting

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

China
Sun Yat-sen University

Unknown

A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study (GITIC)

Gastrointestinal Cancers

China
Indiana University
Pfizer

Completed

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

Breast Cancer

United States
Genentech, Inc.

Terminated

A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B)

Metastatic Breast Cancer
University of Colorado, Denver

Recruiting

Losartan + Sunitinib in Treatment of Osteosarcoma

Osteosarcoma

United States
Xiangya Hospital of Central South University
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST

Gastrointestinal Stromal Tumors

China
US Oncology Research
Pfizer

Completed

Gemzar, Cisp, Sunitinib Urothelial Ca

Urothelial Cancer

United States
Noah Hahn, M.D.
Pfizer; Hoosier Cancer Research Network

Terminated

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Transitional Cell Carcinoma of the Bladder

United States, United Kingdom
University of Chicago
Pfizer

Completed

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

Solid Tumors

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib (ENEST)

Gastrointestinal Stromal Tumors

United States, Australia, Germany, Spain, Korea, Republic of, Canada, France, Poland, Austria, Netherlands, Italy, Czech Republic, Switzerland
Cardiff University

Completed

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer

United Kingdom
Pfizer

Terminated

A Clinical Trial Assessing Efficacy and Safety of Sunitinib and Exemestane in Patients With ER [Estrogen Receptor] + and/or PgR [Progesterone Receptor] + Breast Cancer

Breast Neoplasms

United States, Canada
Stanford University
National Comprehensive Cancer Network

Completed

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

Kidney Neoplasms | Carcinoma, Renal Cell | Kidney (Renal Cell) Cancer

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function

Hepatic Insufficiency | Healthy

United States
CStone Pharmaceuticals

Recruiting

Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World

Gastrointestinal Stromal Tumors

China
Baylor Breast Care Center
Pfizer

Terminated

Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer (EXTENT)

Metastatic Breast Cancer

United States
Hadassah Medical Organization

Unknown

Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib (rcc)

Renal Cell Cancer
Masonic Cancer Center, University of Minnesota

Withdrawn

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Lung Cancer
Genentech, Inc.

Terminated

A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

Non-Small Cell Lung Cancer
Washington University School of Medicine
Pfizer

Completed

A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC) (SU/Rapamycin)

Non-Small Cell Lung Cancer

United States
Institut Català d'Oncologia

Unknown

Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer

Breast Cancer

Spain
GlaxoSmithKline

Completed

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

Carcinoma, Renal Cell
Heidelberg University

Unknown

Molecular Determinants for Therapy Response on Renal Cell Carcinoma (MORE)

Renal Cell Carcinoma

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Renal Cell Carcinoma | Clear-cell Metastatic Renal Cell Carcinoma

United States, Canada
Amsterdam UMC, location VUmc
VitrOmics BV

Terminated

Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study (TSAP)

Advanced Solid Tumors | Metastasis | Inoperable

Netherlands
M.D. Anderson Cancer Center
Pfizer

Completed

Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)

Kidney Cancer | Renal Cell Cancer

United States
Nektar Therapeutics
Bristol-Myers Squibb

Terminated

A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma

United States, Argentina, Brazil, Australia, Singapore, New Zealand, Russian Federation, Mexico, Peru, Chile
Harry Drabkin

Terminated

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Kidney Cancer

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Intraocular Melanoma | Malignant Conjunctival Neoplasm

United States

3

Subscribe